Clinical Trial is one of the key policies in the National Plan of Industrial Center of Asia-Pacific Center of Biomedical Development. Board of Science and Technology invited many academic and industrial institutes, including Academia Sinica, National Science Council, Ministry of Health and Welfare, to develop the Biomedical Island Plan, in order to enhance the level and competence of clinical research in Taiwan. Together with well-established and successful Information Technology industry, Taiwan is on her way to be a major one in the modern biomedical developmental country. This project certainly will put this small island country, Formosa, as the most competitive country in the world.

Standardization, Globalization, and Information system are the critical components for clinical research centers to participate in international clinical trials. Also, rapidly growing biomedical, medical device including IVD industry pushes the validation from laboratory to clinical research. Therefore, designing a GCP-compliant and quality trial becomes a challenge to nowadays Pharmaceutical and biomedical players.

Therefore, Formosa Biomedical Technology Corp. (FBC) extended their business model and established the CRO service division in July, 2006. With the value chain existed in FBC, this new division collaborates with Chang Gung Memorial Hospital (CGMH) and Chang Gung University (CGU); we can provide the contract research service to pharmaceutical, medical device, and IVD companies. High quality services is guaranteed with our qualified and experienced personnel, full knowledge of ICH-GCP standards, and the utilization of the first time ever in Taiwan, the state of art data management, data entry and monitoring package platform which compliant with 21 CFR part 11. FBC CRO service shall bring you the truly high standard clinical trial research services in Taiwan.